CGS-authored
FOR RESEARCH EFFORT TO SUCCEED, TAXPAYERS MUST TRUST HOW $3 BILLION IS HANDED OUT
Mercury News Editorial
Nearly six months after voters approved Proposition 71, Californians are still riveted by their first-in-the-nation stem-cell effort. They should be. It's an audacious $3 billion gamble.
Friday's expected announcement of San Francisco as the permanent headquarters for the agency will be front-page news around the state, but it's actually of little consequence, except as a public-relations coup for Mayor Gavin Newsom. (Memo to Newsom's PR team: Before calling San Francisco the capital of biotech, please recall that as recently as 2004, the city was the home of no publicly traded biotech companies).
The more important decisions will be made when scientists actually start handing out the new agency's $3 billion in grants.
That's why institutional integrity must be among the agency's top goals. Nothing will undermine the success of the stem-cell program more quickly than if Californians don't trust the way the money is distributed.
The California Institute for Regenerative Medicine should get behind legislation by state Sen. Deborah Ortiz, D-Sacramento, to enact...
Mercury News Editorial
Nearly six months after voters approved Proposition 71, Californians are still riveted by their first-in-the-nation stem-cell effort. They should be. It's an audacious $3 billion gamble.
Friday's expected announcement of San Francisco as the permanent headquarters for the agency will be front-page news around the state, but it's actually of little consequence, except as a public-relations coup for Mayor Gavin Newsom. (Memo to Newsom's PR team: Before calling San Francisco the capital of biotech, please recall that as recently as 2004, the city was the home of no publicly traded biotech companies).
The more important decisions will be made when scientists actually start handing out the new agency's $3 billion in grants.
That's why institutional integrity must be among the agency's top goals. Nothing will undermine the success of the stem-cell program more quickly than if Californians don't trust the way the money is distributed.
The California Institute for Regenerative Medicine should get behind legislation by state Sen. Deborah Ortiz, D-Sacramento, to enact...